Showing: 1 - 4 of 4 RESULTS

Zoom is releasing a new tool to let paid users charge for admission to online events like conferences or fitness classes



Eric S. Yuan standing in front of a sign: Eric Yuan, CEO of Zoom Video Communications takes part in a bell ringing ceremony at the NASDAQ MarketSite in New York Reuters


© Provided by Business Insider
Eric Yuan, CEO of Zoom Video Communications takes part in a bell ringing ceremony at the NASDAQ MarketSite in New York Reuters

  • Zoom is introducing OnZoom, a new way to host events — free and paid — using the popular videoconferencing tool.
  • Zoom has come to be used to host all kinds of events amid the pandemic, from board meetings and conferences to fitness classes and concerts. The new OnZoom platform includes the ability to charge for tickets, as well as a directory of public event listings.
  • Zoom is also launching a new kind of app integration, called a Zapp, that can bring information from productivity tools like Dropbox, Slack, or Asana directly into a video chat.
  • Facebook launched its own features for paid videoconferencing events over the summer.
  • Visit Business Insider’s homepage for more stories.

As the pandemic drags on, Zoom is releasing a new way to host online events — importantly, now including paid events — as well as new types of apps that integrate outside business and productivity tools like Slack, Dropbox, and Asana directly into Zoom meetings, the company announced Wednesday. 

Loading...

Load Error

Zoom has become a household name amid shelter in place and social distancing mandates, with users turning to the videoconferencing app to host events from board meetings and conferences to yoga classes and concerts. It’s led Zoom’s business to skyrocket, but also forced the company to rethink its ambitions beyond its original enterprise approach. 

The online event platform, called OnZoom, adds features to Zoom that make it easier to host online events — notably, by allowing event organizers to sell tickets for paid events on Zoom, thanks to an integration with PayPal. There will also be an event marketplace, where people can find and sign up for public events, free and paid.

At launch, the events platform is only available to US users, but will be available more globally next year. There’s no additional fee for paid users to try out OnZoom through the end of 2020, but Zoom says that it plans to revisit the possibility of taking a cut of ticket sales next year. 

Notably, Facebook announced something similar earlier this year, allowing businesses, creators, educators and media publishers to host paid events on Facebook Live or its Messenger Rooms app. Facebook has said it won’t collect fees from tickets sales until at least August 2021.

The catch is that you will have to be a paid Zoom user to set up events with OnZoom, with a capacity ranging from 100 attendees, up to 1,000 for enterprise users. For anything larger, users can livestream the event with a Zoom Webinar license. 

OnZoom is actually getting its first public test right out in the open: Zoom is using it to host its annual Zoomtopia user conference this week. The company bills it as being well-suited for other companies to host their own conferences, for fitness instructors to hold paid lessons, for nonprofits to set up fundraising events

Pain Pill Abuse Higher in Adolescent CBD Oil Users

Adolescent users of cannabidiol (CBD) oil are far more likely to engage in risk-taking behaviors ― such as illegally taking prescription pain medications ― than peers who don’t use CBD, new research indicates.

The study, which included data on 200 youths aged 12 to 23 years, also suggests that 4 in 10 use CBD oil products. Users also reported experiencing increased anxiety over the prior 6 months, but the researchers couldn’t pinpoint whether CBD oil, which is marketed for anxiety relief, might contribute to participants’ anxiety levels.



Nicole Cumbo

“A lot of kids don’t talk to their clinicians about CBD” use, said study author Nicole Cumbo, BS, a third-year medical student at Penn State Milton S. Hershey Medical Center in Hershey, Pennsylvania.

“It’s important to ask kids if they’re using CBD, along with vaping and marijuana use, because it could be causing them more problems than it helps,” Cumbo told Medscape Medical News. “Monitoring for dangerous behaviors in their social history is important. Since we were able to see a correlation between risk-taking behaviors, we should ask kids about risk-taking behaviors as well.”

Touted as a panacea for conditions ranging from insomnia to muscle aches to low mood and more, CBD oil products have become ubiquitous across the United States, Cumbo noted. “Even if you go to a gas station, you see it,” she said. “It’s growing prevalence is apparent, but we weren’t sure what we’d see in our pediatric population.”

Cumbo and colleagues administered questionnaires to adolescents who presented for medical care to a level 1 pediatric trauma center/emergency department affiliated with a children’s hospital in central Pennsylvania. The questionnaire asked about demographics, risk-taking behaviors, and use of CBD oil products. The survey also asked participants about clinical symptoms experienced over the prior 6 months, along with their views on the perceived benefits of using CBD oil.

The average age of the participants was 17.6 years, and 63% were female. Forty percent reported CBD oil use. Compared to nonusers, among those who used CBD oil, there was significantly greater use of prescription medications without a prescription (19% vs 6%; P = .002), as well as greater use of cigarettes (40% vs 8%; P < .0001), chewing tobacco (18% vs 1%; P < .0001), and cigars (30% vs 3%; P < .0001).

No significant differences were found between CBD users and nonusers in symptoms such as chest pain, racing heart, difficulty breathing/cough, dizziness, abdominal discomfort, nausea/vomiting, headache, tremors, sleep disturbances, or dehydration over the prior 6 months.

However, those who used CBD were more likely to report experiencing an increase in anxiety over the prior 6 months (66% vs 47%; P = .009).

Regarding their perceived beliefs about CBD oil, 69% said it is “safer than other drugs,” 33% said it’s “just for fun,” and 48% said it can “help treat my medical illness.” Participants reported that myths about CBD oil include the notions that it’s a gateway drug and that it’s addictive.

“I think there’s a disconnect in

Study: Pot users may need more anesthesia, painkillers during, after surgery

Marijuana users appear to need more anesthesia than nonusers, and also more opioids to relieve their pain after surgery, a new, preliminary study reports.

Users of cannabis products who had surgery for a broken leg required higher doses of sevoflurane, an inhaled anesthetic that keeps you asleep during a procedure. These folks also required nearly 60% more opioid painkillers per day while recuperating in the hospital, the researchers found.

The results jibe with earlier studies indicating that marijuana users might need more anesthesia initially to put them under, said lead author Dr. Ian Holmen, a resident anesthesiologist with the University of Colorado Anschutz Medical Campus in Aurora.

“It’s similar to flying a plane. You have a takeoff section, and then you have your cruising section and then your landing. These in anesthesia are induction, maintenance and emergence,” Holmen said. “We found that it’s not just in the induction phase of anesthesia that you need more anesthesia, but even during that cruising phase you need more inhaled anesthetic.”

The findings were reported Monday at an online meeting of the American Society of Anesthesiologists. Research presented at meetings is typically considered preliminary.

The implications for most marijuana users are not dire, according to Holmen and Dr. David Dickerson, vice chair of the ASA’s Committee on Pain Medicine.

Pot users should simply be honest with their doctors about their marijuana consumption, so they can dial in their anesthetic dose more accurately, said Dickerson.

“We want to know there might be a need for more anesthesia,” he said. “The last thing we want to do is to be under-dosing if someone is going to have an increased requirement. The more information we have, the more we can react and monitor to keep a patient safe during a procedure.”

But marijuana users who have heart or lung health issues might face some danger in the operating room, depending on how much additional anesthetic they need during surgery, Holmen added.

“Sevoflurane has a very clear dose-dependent effect on blood pressure,” he said. “The more sevoflurane you receive in the OR, the more a patient’s blood pressure drops. If you have heart problems or lung problems coming into the OR, it could be dangerous.”

For this study, Holmen and his colleagues reviewed the records of 118 patients who had surgery at the University of Colorado hospital for a broken shin bone.

Of those, 30 patients reported using cannabis. Holmen said that the amount and frequency of use were not recorded, nor was the type of cannabis product used — CBD, THC, edibles or smoked pot.

During surgery, marijuana users not only needed more inhaled sevoflurane anesthetic, but also higher doses of hydromorphone painkillers, the researchers found.

They also reported higher post-surgery levels of pain that needed larger doses of opioid painkillers to quell.

There are a few potential explanations. It could be that marijuana use alters the way that anesthetic and pain medications are processed by the body, Dickerson said.

“Cannabis is metabolized in the liver. Medications

Users of blood pressure medicine have a lower risk of dying from influenza and pneumonia

Drugs to lower blood pressure of the type ACE inhibitors or angiotensin II receptor blockers reduce the mortality rate of influenza and pneumonia.

This is the main conclusion of a new reassuring study published in the Journal of the American Heart Association, which Christian Fynbo Christiansen and a number of Danish colleagues are behind. He is consultant, clinical associate professor and PhD at the Department of Clinical Epidemiology, which is part of the Department of Clinical Medicine at Aarhus University and Aarhus University Hospital in Denmark.

In the study, the researchers have compared mortality rates among 500,000 Danish patients who were admitted to hospitals in Denmark with influenza and pneumonia during the period 2005 to 2018. This has been done by correlating information from the National Patient Register (activity at Danish hospitals) with statistics from the Danish Register of Medicinal Products (the consumption of medicine in Denmark).

“A little over 100,000 of the admitted patients took ACE inhibitors or angiotensin II receptor blockers, and the study shows that fewer of them were put on a ventilator and that they had lower mortality rates than the hospitalised patients who took another type of drugs against elevated blood pressure, calcium blockers,” says Christian Fynbo Christiansen.

The study arrives mid in a discussion of treatment which peaked while the corona pandemic was at its height. Some medical doctors and researchers pointed out that ACE inhibitors may actually have the completely opposite effect – that is increasing the risk of dying from COVID-19 as the virus SARS-CoV-2 which causes COVID-19 enters the lungs through the same ACE receptors as the ACE inhibitors.

The hypothesis was that when the ACE inhibitor reduces the level of ACE, the body compensates for this by activating a much greater number of ACE receptors on the surface of the cells, which the SARS-CoV-2 virus then utilises as some kind of access key. The greater the number of access keys available on the surface of the cells, the more easily the virus gains access to the cells.

The theory about increased mortality has been nurtured by the fact that a strikingly large proportion of the patients who were seriously ill due to COVID-19 had elevated blood pressure, which is extensively treated with ACE inhibitors – of the 600,000 Danes who have elevated blood pressure, approximately one-third ( 200,000) of them take ACE inhibitors.

“We haven’t examined whether what applies to patients with influenza and pneumonia can be transferred directly to patients with COVID-19, but there is some evidence to suggest that ACE inhibitors have a protective effect against lung damage which we don’t see in patients who take other types of medicine to lower blood pressure. The first studies find no correlation between ACE inhibitors/angiotensin II receptor blockers and COVID-19. However, further studies are needed using the good Danish registers,” says Christian Fynbo Christiansen.

In Denmark, the discussion for and against the use of ACE inhibitors on corona patients has taken place (in Danish) in e.g. the Journal of